| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.4M | +13.5% |
| Cost of Revenue | $5.3M | +16.3% |
| R&D Expense | $61.1M | +14.2% |
| SG&A Expense | $33.9M | +5.3% |
| Operating Income | -$82.4M | -4.7% |
| Interest Expense | $11.3M | +61.5% |
| Income Tax | $0 | — |
| Net Income | -$80.7M | -13.7% |
| EPS (Basic) | -$1.01 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $195.8M | +91.4% |
| Accounts Receivable | $26.2M | +22.8% |
| Inventory | $2.3M | +16.8% |
| Current Assets | $232.2M | +79.2% |
| Total Assets | $252.1M | +68.8% |
| Current Liabilities | $34.9M | +11.2% |
| Total Liabilities | $160.9M | +41.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.2M | -17.8% |
| Capital Expenditures | $6.1M | +63.8% |
| Investing Cash Flow | -$6.1M | -63.8% |
| Financing Cash Flow | $169.8M | — |
| Free Cash Flow | -$76.3M | -20.5% |
| -9.8% |
| EPS (Diluted) | -$1.02 | -5.2% |
| Stockholders' Equity |
| $91.1M |
| +157.6% |